What is new in fixed drug eruption?
Shiohara
T
T
D017951:Antigen Presentation / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D003602:Cytotoxicity, Immunologic; D003875:Drug Eruptions / Q000209:etiology* / Q000276:immunology / Q000473:pathology; D004817:Epidermis / Q000187:drug effects / Q000276:immunology / Q000473:pathology; D000939:Epitopes / Q000276:immunology; D006801:Humans; D015603:Keratinocytes / Q000187:drug effects / Q000276:immunology; D008213:Lymphocyte Activation / Q000276:immunology; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000276:immunology; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology
D000939:Epitopes; D016693:Receptors, Antigen, T-Cell, alpha-beta